ClinicalTrials.Veeva

Menu

Application of MR-PET in Colorectal Cancer

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Colorectal Cancer

Treatments

Device: The imaging biomarkers determined by MR-PET

Study type

Observational

Funder types

Other

Identifiers

NCT02553031
201403082MIND

Details and patient eligibility

About

This study will explore the potential value in proper therapeutic decision and clinical outcome prediction by using integrated MR-PET system and advanced MR techniques in patients with colorectal cancer.

Full description

This research expect that the image techniques and experience in this cancer group may be valuable and helpful for others. With advantage of MR-PET in better soft tissue delineation/functional information and less radiation dose than PET-CT, the ultimate goal in both research and clinical application is to establish new diagnostic standard and management guideline by MR-PET, which can further improve clinical outcome and disease prognosis in patients colorectal cancer.

Enrollment

100 estimated patients

Sex

All

Ages

20 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Group 1: Patients with newly diagnosed colorectal cancers
  2. Group 2: Patients with suspicious recurrent colorectal cancers

Exclusion criteria

  1. Age <20 or >90 years old
  2. Contraindication for MRI: claustrophobia or MR non-compatible devices
  3. Contraindication for MR contrast medium: severe adverse reaction or impaired renal function (Cre > 2.0)
  4. History of other malignancy
  5. Prior arthroplasty of hip (may cause artifacts on MRI)
  6. Pregnancy

Trial contacts and locations

1

Loading...

Central trial contact

Ting-Fang Shih, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems